How to Deal with Scary Headlines

Katherine Anagnostou, MD, MSc, PhD, FAAAAI, discusses the evolution and current approaches towards food allergy diagnosis and management. Listen to learn which food allergy advice is now outdated, incorrect and harmful.

Allison Burbank, MD, offers a detailed and extremely insightful conversation surrounding the latest approaches towards asthma management and goals of therapy. 

Vivian Hernandez-Trujillo, MD, FAAAAI, offers a sneak peek at the exciting 2024 AAAAI Practice Management Workshop taking place July 12-14 in Denver, CO. You won’t want to miss this one!

AAAAI President Paul V. Williams, MD, FAAAAI, discusses how his three Presidential initiatives are designed to help patients and allergists. Listen now to learn more!

Psychologist Linda Herbert, PhD, discusses the powerful impact that headlines and scary stories can have on people with food allergies and other allergic conditions. 

Robert Wood, MD, FAAAAI, discusses the exciting new FDA approval for using Omalizumab to treat food allergies. This is a must listen for allergists and patients as Dr. Wood offers insight and information related to the research findings and best practices for using this new treatment.

Joshua Boyce, MD, FAAAAI, discusses an exciting addition to the AAAAI Annual Meeting. Listen now to learn more about what the entire meeting has in store.

Derek Chu, MD, PhD, discusses the newly published atopic dermatitis practice parameters, including treatment recommendations and best practices for management. This conversation is filled with useful information, context and perspective to complement the parameters.

David Golden, MD, FAAAAI, returns to discuss important highlights and offer perspective from the new anaphylaxis practice parameters. With several new and potentially controversial recommendations, this is a must listen episode.

Thanai Pongdee, MD, FAAAAI, discusses why this long-standing and commonly used medication is being discontinued and offers valuable advice on options for those with asthma or eosinophilic esophagitis to consider.